Scientists reveal how G protein-coupled receptors, major therapeutic drug targets, decode critical properties of their ligands. Through an international collaboration, scientists at St. Jude ...
Recent years have seen major advances in understanding the structure-function relationships of G protein-coupled receptors (GPCRs). This large superfamily of transmembrane receptors comprises over 800 ...
DISCOVERY OF THE ATOMIC STRUCTURE OF A LIGAND-FREE G PROTEIN-COUPLED RECEPTOR (GPCR) WILL HELP DESIGN MORE EFFECTIVE DRUGS NEW YORK (February 26, 2013) — A research team at Weill Cornell Medical ...
An AI-driven computational toolkit, Gcoupler, integrates ligand design, statistical modeling, and graph neural networks to predict endogenous metabolites that allosterically modulate the GPCR–Gα ...
Scientists from The Scripps Research Institute have determined the structure of a new neurological receptor, A2A adenosine receptor, from within a larger group of four GPCRs that play an essential ...
Structure Therapeutics (GPCR) has been capturing some attention lately, especially after its shares posted gains of more than 40% over the past month. Investors are curious whether this momentum can ...
Novo Nordisk NVO and Structure Therapeutics GPCR have emerged as noteworthy companies in the obesity space. A market leader in the GLP-1 space, Novo Nordisk markets its semaglutide drugs under brand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback